VRCA Verrica Pharmaceuticals Inc: Bozor qiymatining balans qiymatiga nisbati

verrica.com (VRCA) - korporativ logo

Verrica Pharmaceuticals (VRCA) narx trayektoriyasi uning mollyuskumni davolash usulini tijoratlashtirish ta'sirini ko'rsatadi, bu esa hozirgi 13.44 darajasida operatsion ta'sirni faollashtiradi. Biznes teri terapiyasi uchun noyob topikal tizimlar va aplikatorlarni yaratishga tayanadi. Kompaniyaning muvaffaqiyati dermatologlar va ilg'or tibbiyot sohasida martaba o'sishi imkoniyatlarini qadrlaydigan mutaxassislar o'rtasidagi sinergiyaga asoslangan.

verrica.com (VRCA) - Balans qiymatiga nisbatan bozor qiymati 04.07.2022dan 31.10.2026gacha
verrica.com ishlab chiqargan mahsulot

Verrica Pharmaceuticals (VRCA) uchun fundamental risklar bozor qiymatini sof aktivlar qiymati bilan solishtirish orqali aniqlanadi. Inertia dori vositasidan tushadigan barqaror pul oqimi biznesning moliyaviy barqarorligini ta'minlaydi. Joriydagi narxning buxgalteriya qiymatiga nisbati tendentsiyasi aksiyalar narxi va kapitalning buxgalteriya qiymati o'rtasidagi proporsiyani namoyish etadi. Koeffitsiyentning oshishi aktivlarning haddan tashqari yuqori baholanganligidan dalolat bersa, pasayishi chegirma mavjudligini ko'rsatadi. Ushbu metrikaning tahlili kompaniya qizib ketganmi yoki past baholanganmi ekanligini aniqlash imkonini beradi.

Raqobatchilar tahlili

KRYS: Bozor kapitallashuvining balans qiymatiga nisbati|apogeetherapeutics.com (APGE) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Arcutis Biotherapeutics, Inc.|Vericel Corp - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ORKA|SMTI (sanaramedtech.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati DBVT (DBV Technologies)|Bozor kapitallashuvining balans qiymatiga nisbati Solesence Beauty SLSN|DERM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati FBRX (Forte Biosciences Inc.)|Empro (EMPG) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Sol-Gel Technologies, Ltd.|AXIL (AXIL Brands Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati medicuspharma.com|Kapitallashuvning sof aktivlarga nisbati HOTH (Hoth Therapeutics, Inc.)|BFRI (biofrontera-us.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati VYNE Therapeutics Inc. VYNE|Balans qiymatiga nisbatan bozor kapitallashuvi Sonoma Pharmaceuticals Inc. (SNOA)|QNRX - Bozor qiymatining balans qiymatiga nisbati|AZTR - Bozor kapitallashuvining balans qiymatiga nisbati|DRMA: Bozor kapitallashuvining balans qiymatiga nisbati|ELAB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Revance Therapeutics, Inc